Patients exposed to a higher dose may be subject to bleeding complications. Apotex Corp announced the voluntary recall of 2 batches of Enoxaparin Sodium Injection ...
Syringe marking errors, which can lead to incorrect dosing, caused a recall of Enoxaparin Sodium Injection, a generic version of blood clot medication Lovenox. The recall issued Tuesday by Apotex, a ...
LANGHORNE, Pa.--(BUSINESS WIRE)--#Enoxaparin--Techdow USA Inc. (“Techdow USA”), a growing market leader and vertically integrated generic injectables company, today announced the launch of its 30mg, ...
WESTON, Fla., Feb. 2, 2021 /CNW/ - Apotex Corp is voluntarily recalling two (2) batches of Enoxaparin Sodium Injection, USP to consumer level due to a packaging error ...
Techdow USA Inc., a division of the Hepalink Group (Techdow USA), has announced its next finished drug product launch, Enoxaparin Sodium (Enoxaparin). This product is expected to launch in June of ...
(RTTNews) - Sandoz, Inc., an unit of Novartis Pharma AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high ...
Princeton, New Jersey, April 25, 2012 – Sandoz today announced the introduction of enoxaparin sodium injection, USP 3 mL vials, a generic version of Sanofi's Lovenox® Injection Multiple-Dose Vials, in ...
The Cabinet of Ministers granted approval for the resolutions furnished by the Minister of Health to award procurements based on the recommendations of the Standing Procurement Committee appointed by ...
Please provide your email address to receive an email when new articles are posted on . Techdow USA announced the FDA approval of its generic enoxaparin sodium for marketing in the U.S. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback